(ITB) Imperial Brands - Ratings and Ratios
Exchange: XETRA • Country: United Kingdom • Currency: EUR • Type: Common Stock • ISIN: GB0004544929
ITB: Cigarettes, Tobacco, Vapour, Heated, Nicotine, Accessories
Imperial Brands PLC, a company with roots tracing back to 1901, stands as a global powerhouse in the tobacco industry, operating across Europe, the Americas, Africa, Asia, and Australasia. Beyond its core tobacco products, the company has diversified into vapour, heated tobacco, and oral nicotine offerings, adapting to evolving consumer preferences. Its brand portfolio, which includes JPS, Davidoff, and Gauloises, reflects a strategic mix of heritage and innovation.
The company’s operational breadth extends beyond manufacturing and distribution. It distributes non-tobacco products, manages golf courses, and even dabbles in pharmaceutical distribution and logistics. This diversification isn’t just about spreading risk; it’s about building a resilient business model that can weather sector-specific headwinds. With a market cap of €23.26 billion, Imperial Brands is no small player, and its P/E ratio of 9.96 suggests it may be undervalued compared to its peers.
Investors should note the company’s dividend yield, which, while not explicitly stated here, has historically been attractive for income-focused investors. However, the tobacco sector’s regulatory environment remains challenging. Imperial Brands is countering this by investing in R&D, particularly in e-vapour products, aiming to capture growth in the smoke-free category. This strategic shift could be pivotal for long-term value creation.
From a financial health perspective, the company’s price-to-book ratio of 4.29 indicates that investors are paying a premium for its assets, which could be a red flag for value investors. However, its price-to-sales ratio of 1.28 suggests the market is pricing in growth potential. The forward P/E of 9.32 hints at expectations of improved earnings, but investors should scrutinize whether these expectations are realistic given the sector’s challenges.
Imperial Brands’ history, dating back over a century, speaks to its endurance, but its future will likely be shaped by its ability to navigate regulatory landscapes and consumer trends. For fund managers, this stock could offer a mix of stability and growth, but it’s crucial to weigh these factors against the broader sector risks and the company’s ability to execute its strategic vision.
Additional Sources for ITB Stock
ITB Stock Overview
Market Cap in USD | 32,570m |
Sector | Consumer Defensive |
Industry | Tobacco |
GiC Sub-Industry | Tobacco |
IPO / Inception |
ITB Stock Ratings
Growth Rating | 62.8 |
Fundamental | 82.4 |
Dividend Rating | 81.5 |
Rel. Strength | 55.1 |
Analysts | - |
Fair Price Momentum | 36.65 EUR |
Fair Price DCF | 153.18 EUR |
ITB Dividends
Dividend Yield 12m | 6.83% |
Yield on Cost 5y | 11.07% |
Annual Growth 5y | 26.07% |
Payout Consistency | 100.0% |
ITB Growth Ratios
Growth Correlation 3m | 46.8% |
Growth Correlation 12m | 98.4% |
Growth Correlation 5y | 93.7% |
CAGR 5y | 34.70% |
CAGR/Max DD 5y | 1.98 |
Sharpe Ratio 12m | 3.25 |
Alpha | 69.61 |
Beta | 0.168 |
Volatility | 24.47% |
Current Volume | 16k |
Average Volume 20d | 18.8k |
As of April 22, 2025, the stock is trading at EUR 34.74 with a total of 16,027 shares traded.
Over the past week, the price has changed by +2.66%, over one month by +7.42%, over three months by +15.39% and over the past year by +73.30%.
Yes, based on ValueRay Fundamental Analyses, Imperial Brands (XETRA:ITB) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 82.39 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ITB as of April 2025 is 36.65. This means that ITB is currently overvalued and has a potential downside of 5.5%.
Imperial Brands has no consensus analysts rating.
According to ValueRays Forecast Model, ITB Imperial Brands will be worth about 39.6 in April 2026. The stock is currently trading at 34.74. This means that the stock has a potential upside of +13.93%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 39.6 | 13.9% |